Zobrazeno 1 - 8
of 8
pro vyhledávání: '"José F. Tomas"'
Autor:
Juan F. García, Miguel A. Piris, Manolo M. Morente, José F. Tomas, Pedro Sánchez-Godoy, Angel Castaño, Eulogio Conde, Francisco Mazorra, Miguel Mendez, Maria J. Mestre, Cesar Morante, Manuel F. Fresno, Carmen Bellas, Concepción Poderos, Joaquín González-Carrero, Rafael Martinez, Carmen Martin, Carlos Montalbán, Abel Sánchez-Aguilera, Beatriz Sánchez-Espiridión
Purpose: Despite major advances in the treatment of classic Hodgkin's lymphoma (cHL), ∼30% of patients in advanced stages may eventually die as result of the disease, and current methods to predict prognosis are rather unreliable. Thus, the applica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e7ed9fe8b284537352f95352dd1eb6a
https://doi.org/10.1158/1078-0432.c.6517338
https://doi.org/10.1158/1078-0432.c.6517338
Autor:
Juan F. García, Miguel A. Piris, Manolo M. Morente, José F. Tomas, Pedro Sánchez-Godoy, Angel Castaño, Eulogio Conde, Francisco Mazorra, Miguel Mendez, Maria J. Mestre, Cesar Morante, Manuel F. Fresno, Carmen Bellas, Concepción Poderos, Joaquín González-Carrero, Rafael Martinez, Carmen Martin, Carlos Montalbán, Abel Sánchez-Aguilera, Beatriz Sánchez-Espiridión
Supplementary Data from A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55ff2ba2d06b26de88613013f98e5776
https://doi.org/10.1158/1078-0432.22439955.v1
https://doi.org/10.1158/1078-0432.22439955.v1
Autor:
Marina Testa, José F. Tomas, Anna Locasciulli, Per Ljungman, Maria Grazia Valsecchi, Stefano Solinas, Alfredo Alberti, Andrea Bacigalupo
Publikováno v:
Transplantation. 68:1486-1491
Background. Severe liver disease, including fulminant hepatic failure and venoocclusive disease can occur after bone marrow transplantation (BMT). The aim of our study was to assess risk factors for veno occlusive disease and severe liver disease occ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c76a710e81bda9b5f737678b3463adc4
https://doi.org/10.1097/00007890-199911270-00010
https://doi.org/10.1097/00007890-199911270-00010
Autor:
Rafael, Rojas, José R, Molina, Isidro, Jarque, Carmen, Montes, Josefina, Serrano, Jaime, Sanz, Juan, Besalduch, Enric, Carreras, José F, Tomas, Luis, Madero, Daniel, Rubio, Eulogio, Conde, Miguel A, Sanz, Antonio, Torres
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 4, Iss 1, Pp e2012011-e2012011 (2012)
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases
Invasive mold infection (IMI) remains a major cause of mortality in high-risk hematological patients. The aim of this multicenter retrospective, observational study was to evaluate antifungal combination therapy for proven and probable IMI in hematol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb3cd6b468ef1476d0bc5893cc2d289a
http://www.mjhid.org/article/view/9832
http://www.mjhid.org/article/view/9832
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Javier Briones, Silvana Novelli, José A. García-Marco, José F. Tomás, Teresa Bernal, Carlos Grande, Miguel A. Canales, Antonio Torres, José M. Moraleda, Carlos Panizo, Isidro Jarque, Francisca Palmero, Miguel Hernández, Eva González-Barca, Dulce López, Dolores Caballero
Publikováno v:
Haematologica, Vol 99, Iss 7 (2014)
Externí odkaz:
https://doaj.org/article/4e30dc2dd58b4a66b65d8a4b369d6968
Autor:
Javier Briones, Silvana Novelli, José A. García-Marco, José F. Tomás, Teresa Bernal, Carlos Grande, Miguel A. Canales, Antonio Torres, José M. Moraleda, Carlos Panizo, Isidro Jarque, Francisca Palmero, Miguel Hernández, Eva González-Barca, Dulce López, Dolores Caballero
Publikováno v:
Haematologica, Vol 99, Iss 3 (2014)
Lymphoma patients with persistent disease undergoing autologous transplantation have a very poor prognosis in the rituximab era. The addition of radioimmunotherapy to the conditioning regimen may improve the outcome for these patients. In a prospecti
Externí odkaz:
https://doaj.org/article/a0589924c88d474ab99f7420fe5dd316
Publikováno v:
Haematologica, Vol 97, Iss 2 (2012)
Externí odkaz:
https://doaj.org/article/c834376a19be4c66a29f60d52545f451